MMP10 and breast carcinoma: A study conducted on MCF-7 cell lines and intact uterus rats demonstrated that trilostane can up-regulate β-estrogen receptor expression and suppress specific estrogen-regulated genes, such as MMP-10, suggesting its potential in managing tamoxifen-resistant breast cancer [80].